United States · FDA National Drug Code directory
Moexipril Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-209_66bb1c8f-1f66-4834-86a3-a387d076aa22
- Product NDC
- 68462-209
- Form
- TABLET, FILM COATED
- Composition / generic term
- Moexipril Hydrochloride
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101231
- Source listing expiry
- 20271231
Source-listed ingredients
- MOEXIPRIL HYDROCHLORIDE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (68462-209-01) · 68462-209-01
- 1000 TABLET, FILM COATED in 1 BOTTLE (68462-209-10) · 68462-209-10
- 90 TABLET, FILM COATED in 1 BOTTLE (68462-209-90) · 68462-209-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →